| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1189013
[patent_doc_number] => 06734162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-05-11
[patent_title] => 'Mixed buffer system for stabilizing polypeptide formulations'
[patent_app_type] => B2
[patent_app_number] => 09/733738
[patent_app_country] => US
[patent_app_date] => 2000-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7732
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/734/06734162.pdf
[firstpage_image] =>[orig_patent_app_number] => 09733738
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/733738 | Mixed buffer system for stabilizing polypeptide formulations | Dec 7, 2000 | Issued |
Array
(
[id] => 1342466
[patent_doc_number] => 06586405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-01
[patent_title] => 'Non-covalent inhibitors of urokinase and blood vessel formation'
[patent_app_type] => B2
[patent_app_number] => 09/733645
[patent_app_country] => US
[patent_app_date] => 2000-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 18
[patent_no_of_words] => 30568
[patent_no_of_claims] => 90
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/586/06586405.pdf
[firstpage_image] =>[orig_patent_app_number] => 09733645
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/733645 | Non-covalent inhibitors of urokinase and blood vessel formation | Dec 6, 2000 | Issued |
Array
(
[id] => 1334707
[patent_doc_number] => 06596845
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-22
[patent_title] => 'Cinnamoyl distamycin analogous derivatives, process for their preparation, and their use as antitumor agents'
[patent_app_type] => B1
[patent_app_number] => 09/701557
[patent_app_country] => US
[patent_app_date] => 2000-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5969
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596845.pdf
[firstpage_image] =>[orig_patent_app_number] => 09701557
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/701557 | Cinnamoyl distamycin analogous derivatives, process for their preparation, and their use as antitumor agents | Dec 3, 2000 | Issued |
Array
(
[id] => 1248492
[patent_doc_number] => 06673807
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-06
[patent_title] => 'Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins'
[patent_app_type] => B1
[patent_app_number] => 09/646886
[patent_app_country] => US
[patent_app_date] => 2000-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8925
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/673/06673807.pdf
[firstpage_image] =>[orig_patent_app_number] => 09646886
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/646886 | Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins | Nov 30, 2000 | Issued |
Array
(
[id] => 5859841
[patent_doc_number] => 20020123468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease'
[patent_app_type] => new
[patent_app_number] => 09/728653
[patent_app_country] => US
[patent_app_date] => 2000-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48391
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123468.pdf
[firstpage_image] =>[orig_patent_app_number] => 09728653
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/728653 | Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease | Nov 30, 2000 | Issued |
Array
(
[id] => 6622072
[patent_doc_number] => 20020065228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Insecticidal peptidomimetics of trypsin modulating oostatic factor'
[patent_app_type] => new
[patent_app_number] => 09/727236
[patent_app_country] => US
[patent_app_date] => 2000-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6391
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20020065228.pdf
[firstpage_image] =>[orig_patent_app_number] => 09727236
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/727236 | Insecticidal peptidomimetics of trypsin modulating oostatic factor | Nov 29, 2000 | Abandoned |
| 09/701488 | Process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2 | Nov 28, 2000 | Abandoned |
Array
(
[id] => 6622079
[patent_doc_number] => 20020065229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Anti-S-phase tubulin ligands'
[patent_app_type] => new
[patent_app_number] => 09/725030
[patent_app_country] => US
[patent_app_date] => 2000-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6949
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20020065229.pdf
[firstpage_image] =>[orig_patent_app_number] => 09725030
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/725030 | Anti-S-phase tubulin ligands | Nov 28, 2000 | Issued |
Array
(
[id] => 1582193
[patent_doc_number] => 06423823
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-23
[patent_title] => 'Organic chemical compounds and method for producing the same'
[patent_app_type] => B1
[patent_app_number] => 09/555922
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12795
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/423/06423823.pdf
[firstpage_image] =>[orig_patent_app_number] => 09555922
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/555922 | Organic chemical compounds and method for producing the same | Nov 27, 2000 | Issued |
Array
(
[id] => 1170635
[patent_doc_number] => 06753408
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-22
[patent_title] => 'Peptides having antiangiogenic activity'
[patent_app_type] => B1
[patent_app_number] => 09/718591
[patent_app_country] => US
[patent_app_date] => 2000-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16788
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/753/06753408.pdf
[firstpage_image] =>[orig_patent_app_number] => 09718591
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/718591 | Peptides having antiangiogenic activity | Nov 21, 2000 | Issued |
Array
(
[id] => 1451267
[patent_doc_number] => 06455669
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'Glycopeptide derivatives and pharmaceutical compositions containing the same'
[patent_app_type] => B1
[patent_app_number] => 09/674456
[patent_app_country] => US
[patent_app_date] => 2000-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29611
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455669.pdf
[firstpage_image] =>[orig_patent_app_number] => 09674456
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/674456 | Glycopeptide derivatives and pharmaceutical compositions containing the same | Oct 31, 2000 | Issued |
Array
(
[id] => 1143003
[patent_doc_number] => 06777535
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-17
[patent_title] => 'N-alkylated peptides having antiangiogenic activity'
[patent_app_type] => B1
[patent_app_number] => 09/703233
[patent_app_country] => US
[patent_app_date] => 2000-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22753
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 382
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/777/06777535.pdf
[firstpage_image] =>[orig_patent_app_number] => 09703233
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/703233 | N-alkylated peptides having antiangiogenic activity | Oct 30, 2000 | Issued |
| 09/381055 | NOVEL USE | Oct 29, 2000 | Abandoned |
Array
(
[id] => 1093143
[patent_doc_number] => 06825186
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-30
[patent_title] => 'Method and compositions for treating atheroma, tumors and other neoplastic tissue'
[patent_app_type] => B1
[patent_app_number] => 09/699027
[patent_app_country] => US
[patent_app_date] => 2000-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 15949
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/825/06825186.pdf
[firstpage_image] =>[orig_patent_app_number] => 09699027
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/699027 | Method and compositions for treating atheroma, tumors and other neoplastic tissue | Oct 26, 2000 | Issued |
Array
(
[id] => 1298803
[patent_doc_number] => 06627732
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-30
[patent_title] => 'Glutathione derivatives and their dosage forms'
[patent_app_type] => B1
[patent_app_number] => 09/673449
[patent_app_country] => US
[patent_app_date] => 2000-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17108
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/627/06627732.pdf
[firstpage_image] =>[orig_patent_app_number] => 09673449
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/673449 | Glutathione derivatives and their dosage forms | Oct 15, 2000 | Issued |
Array
(
[id] => 7628073
[patent_doc_number] => 06806363
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-19
[patent_title] => 'Cobalamin conjugates useful as antitumor agents'
[patent_app_type] => B1
[patent_app_number] => 09/690197
[patent_app_country] => US
[patent_app_date] => 2000-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13708
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/806/06806363.pdf
[firstpage_image] =>[orig_patent_app_number] => 09690197
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/690197 | Cobalamin conjugates useful as antitumor agents | Oct 15, 2000 | Issued |
| 09/686627 | Manufacture of polyglutamate-therapeutic agent conjugates | Oct 11, 2000 | Abandoned |
Array
(
[id] => 1181499
[patent_doc_number] => 06737410
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-18
[patent_title] => 'Inhibitors of protein farnesyl transferase'
[patent_app_type] => B1
[patent_app_number] => 09/678554
[patent_app_country] => US
[patent_app_date] => 2000-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13501
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/737/06737410.pdf
[firstpage_image] =>[orig_patent_app_number] => 09678554
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/678554 | Inhibitors of protein farnesyl transferase | Oct 3, 2000 | Issued |
| 09/646020 | Cyclooctadepsipeptides and their use for combating endoparasites | Oct 2, 2000 | Abandoned |
Array
(
[id] => 1120065
[patent_doc_number] => 06797699
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-28
[patent_title] => 'Neuroprotective agents'
[patent_app_type] => B1
[patent_app_number] => 09/581397
[patent_app_country] => US
[patent_app_date] => 2000-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11305
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 341
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/797/06797699.pdf
[firstpage_image] =>[orig_patent_app_number] => 09581397
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/581397 | Neuroprotective agents | Oct 1, 2000 | Issued |